DocDollars

Melinta Therapeutics, LLC

NJ · United States · Reporting entity ID 100000196838

Total reported 2019–2025
$8.46M
#546 of 2,960 reporting companies — 0% of all reported industry payments
$3.67M in general payments across 41,842 records, plus $4.79M in research funding across 496 records.

How it breaks down

General payments $3,671,780
Research funding $4,788,141

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Melinta Therapeutics, LLC reported $8.46M to US doctors and teaching hospitals from 2019 to 2025, ranking #546 of 2,960 reporting companies. 57% of that was research funding and 43% general payments such as consulting, speaking, food and travel. 41,842 general payment records and 496 research records were filed.

Common questions about Melinta Therapeutics, LLC

How much has Melinta Therapeutics, LLC paid US doctors?

Melinta Therapeutics, LLC reported $8,459,921 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,671,780 in general payments, $4,788,141 in research funding.

How does Melinta Therapeutics, LLC rank among drug and device companies?

It ranks #546 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Melinta Therapeutics, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.